Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvant systemic therapy for breast cancer

M J Piccart1, L Biganzoli, J A Roy

  • 1Institut Jules Bordet, Chemotherapy Unit, Brussels, Belgium.

Current Opinion in Oncology
|November 1, 1996
PubMed
Summary

Recent breast cancer research highlights practical guidelines for node-negative treatment and explores new chemotherapy strategies. Studies also provide data on tamoxifen duration and address therapy toxicity and quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancer.

ESMO open·2026
Same author

Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.

Tumori·2025
Same author

PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)].

Cancer treatment reviews·2025
Same author

Adequate assessment yields appropriate care-the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group.

ESMO open·2024
Same author

The new oral SERDs in endocrine-resistant breast cancer: who will benefit the most?

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Area of Science:

  • Oncology
  • Clinical Medicine

Background:

  • Adjuvant systemic therapy for breast cancer is an evolving field.
  • Key areas of recent focus include prognostic factors, novel therapeutic strategies, and treatment-related toxicities.

Purpose of the Study:

  • To review and summarize recent advancements in adjuvant systemic therapy for breast cancer.
  • To highlight practical recommendations and new data impacting clinical practice.

Main Methods:

  • Literature review of studies published within the past year.
  • Analysis of consensus panel recommendations and clinical trial data.

Main Results:

  • Consensus panel issued practical recommendations for node-negative breast cancer treatment based on validated factors.

Related Experiment Videos

  • New data emerged on increasing chemotherapy dose intensity and incorporating novel agents.
  • Clinical trials provided new insights into optimal tamoxifen duration.
  • Increased attention to therapy toxicity and quality of life preservation.
  • Conclusions:

    • Recent advancements offer improved guidance for breast cancer treatment.
    • Future research and clinical practice will likely incorporate refined prognostic assessments and therapeutic approaches.
    • Balancing treatment efficacy with patient quality of life is a growing consideration.